Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948071 · ClinicalTrials.gov registry record · NA
Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis
A NA study of Appendicitis Acute and Appendicitis Perforated, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06948071 is a NA study of Appendicitis Acute and Appendicitis Perforated that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06948071, a NA study of Appendicitis Acute and Appendicitis Perforated, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The exploratory objective of this pilot study is to evaluate the feasibility and safety of an enhanced recovery protocol that will allow adult patients to be discharged to home on an oral antibiotic regimen for three days following a laparoscopic appendectomy for complicated appendicitis. Feasibility will be determined by high compliance and adherence of patients to the postoperative instructions, while safety will be assessed by the incidence of postoperative infectious complications and requirement for re-admission.
Conditions Studied
Interventions
- OTHER Discharge on oral antibiotics
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06948071
The ClinicalTrials.gov registry entry for NCT06948071 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Appendicitis Acute appearing as the primary indexed condition, and to 1 intervention - of which Discharge on oral antibiotics is the first listed.
NCT06948071 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06948071 about?
NCT06948071 is a clinical study titled "Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis". The exploratory objective of this pilot study is to evaluate the feasibility and safety of an enhanced recovery protocol that will allow adult patients to be discharged to home on an oral antibiotic regimen for three days following a laparoscopic appendectomy for complicated appendicitis. Feasibilit...
What is the current status of trial NCT06948071?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-21. Estimated completion is 2026-02-28.
What conditions does trial NCT06948071 study?
This clinical trial studies the following conditions: Appendicitis Acute, Appendicitis Perforated, Appendicitis With Perforation, Appendicitis Suppurative, Appendicitis Gangrenous.
What interventions are being tested in trial NCT06948071?
The interventions under investigation include: Discharge on oral antibiotics (OTHER).
Who is sponsoring clinical trial NCT06948071?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06948071 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appendicitis Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.